Medline Inc.
MDLN· Nasdaq
MDLNMedline Inc.
Filed Aug 5, 2026 · 10-Q · 39 days after period end · 0002046386-26-000051
| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Revenue | $7.69B | $6.89B |
| Net Income | $139.00M | $329.00M |
| EPS Diluted | $0.07 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medline Inc. · CIK 2046386 · Engraved from SEC EDGAR
ended Jun 27, 2026 · filed Aug 5, 2026 · 39 d after period end
